Publicaciones - IR Sant Pau

Buscar

01/02/2022 Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry

El-Chami, MF, Garweg, C, Iacopino, S, Al-Samadi, F, Martinez-Sande, JL, Tondo, C, Johansen, JB, Prat, XV, Piccini, JP, Cha, YM, Grubman, E, Bordachar, P, Roberts, PR, Soejima, K, Stromberg, K, Fagan, DH, Clementy, N. Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry. HEART RHYTHM. 2022; 19(2)DOI:10.1016/j.hrthm.2021.10.023. PMID:34757189. IF:5.500(Q2/3D).

01/02/2022 Ruptured sinus of Valsalva aneurysm: A reversible cause of suprasystemic pulmonary hypertension

Asmarats, L, Bethencourt, A, Rodriguez, A, Noris, M, Maristany, J, Grau, A, Gomez-Jaume, A, Peral, V. Ruptured sinus of Valsalva aneurysm: A reversible cause of suprasystemic pulmonary hypertension. Revista Portuguesa de Cardiologia. 2022; 41(2)DOI:10.1016/j.repc.2018.10.016. PMID:36062706. IF:1.800(Q4/8D).

01/02/2022 Usefulness of Cardiac Computed Tomography in Coronary Risk Prediction: A Five-Year Follow-Up of the SPICA Study (Secure Prevention with Imaging of the Coronary Arteries)

Vilades-Medel, D, Degano, IR, Subirana, I, Descalzo, M, Padilla, M, Mundet, X, Costa, FC, Serrallach, XA, Camps, A, Elosua, R, Marrugat, J, Petracca, RL. Usefulness of Cardiac Computed Tomography in Coronary Risk Prediction: A Five-Year Follow-Up of the SPICA Study (Secure Prevention with Imaging of the Coronary Arteries). Journal of Clinical Medicine. 2022; 11(3)DOI:10.3390/jcm11030533. PMID:35159985. IF:3.900(Q2/4D).

01/02/2022 Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study

Jimenez-Yuste, V, Alvarez-Roman, MT, Bravo, AP, Galmes, BJ, Hernandez, MDN, Hidalgo, OB, Alonso, CM, Gonzalez, NFP, Coll, J, Nunez, R, Carrasco, M, Candel, FG, Gonzalez-Porras, JR, Garcia, CH, Castro, MJV, Mir, R. Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2022; 28DOI:10.1177/10760296221074348. PMID:35108125. IF:2.900(Q3/6D).

01/02/2022 Network-Assisted Systems Biology Analysis of the Mitochondrial Proteome in a Pre-Clinical Model of Ischemia, Revascularization and Post-Conditioning

Gallinat, A, Vilahur, G, Padro, T, Badimon, L. Network-Assisted Systems Biology Analysis of the Mitochondrial Proteome in a Pre-Clinical Model of Ischemia, Revascularization and Post-Conditioning. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042087. PMID:35216205. IF:5.600(Q1/3D).

01/02/2022 Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells

Benitez-Amaro, A, Martinez-Bosch, N, Manero-Ruperez, N, Claudi, L, Lhoest, MTL, Soler, M, Ros-Blanco, L, Navarro, P, Llorente-Cortes, V. Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells. Cancers. 2022; 14(4)DOI:10.3390/cancers14040890. PMID:35205638. IF:5.200(Q2/3D).

01/02/2022 Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis

Nunez, E, Fuster, V, Gomez-Serrano, M, Valdivielso, JM, Fernandez-Alvira, JM, Martinez-Lopez, D, Rodriguez, JM, Bonzon-Kulichenko, E, Calvo, E, Alfayate, A, Bermudez-Lopez, M, Escola-Gil, JC, Fernandez-Friera, L, Cerro-Pardo, I, Mendiguren, JM, Sanchez-Cabo, F, Sanz, J, Ordovas, JM, Blanco-Colio, LM, Garcia-Ruiz, JM, Ibanez, B, Lara-Pezzi, E, Fernandez-Ortiz, A, Martin-Ventura, JL, Vazquez, J. Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis. EBioMedicine. 2022; 76DOI:10.1016/j.ebiom.2022.103874. PMID:35152150. IF:11.100(Q1/1D).

01/02/2022 Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data

Magliano, DJ, Chen, L, Carstensen, B, Gregg, EW, Pavkov, ME, Salim, A, Andes, LJ, Balicer, R, Baviera, M, Chan, JCN, Cheng, YLJ, Gardiner, H, Gulseth, HL, Gurevicius, R, Ha, KH, Jermendy, G, Kim, DJ, Kiss, Z, Leventer-Roberts, M, Lin, CY, Luk, AOY, Ma, S, Mata-Cases, M, Mauricio, D, Nichols, GA, Pildava, S, Porath, A, Read, SH, Robitaille, C, Roncaglioni, MC, Ruiz, PLD, Wang, KL, Wild, SH, Yekutiel, N, Shaw, JE. Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data. Lancet Diabetes & Endocrinology. 2022; 10(2)DOI:10.1016/S2213-8587(21)00327-2. PMID:35026157. IF:44.500(Q1/1D).

01/02/2022 Compliance with the DPP-4 inhibitors dose adjustment recommendations based onrenal function in a population database

Franch-Nadal, J, Real, J, Mata-Cases, M, Ortega, E, Valles, JA, Vlacho, B, Mauricio, D. Compliance with the DPP-4 inhibitors dose adjustment recommendations based onrenal function in a population database. Endocrinologia Diabetes y Nutricion. 2022; 69(2)DOI:10.1016/j.endinu.2021.01.013. PMID:34088634. IF:1.900(Q4/9D).

01/02/2022 Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834

Meek, CL, Oram, RA, McDonald, TJ, Feig, DS, Hattersley, AT, Murphy, HR, Corcoy R., CHICO BALLESTEROS, ANA ISABEL, CONCEPTT Collaborative Grp. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834. DIABETES CARE. 2022; 45(2)DOI:10.2337/dci21-0054. PMID:35050370. IF:16.200(Q1/1D).

01/02/2022 Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response

Gil, J, Marques-Pamies, M, Valassi, E, Garcia-Martinez, A, Serra, G, Hostalot, C, Fajardo-Montanana, C, Carrato, C, Bernabeu, I, Marazuela, M, Rodriguez-Lloveras, H, Camara, R, Salinas, I, Lamas, C, Biagetti, B, Simo-Servat, A, Webb, SM, Pico, A, Jorda, M, Puig-Domingo, M. Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response. Biomedicines. 2022; 10(2)DOI:10.3390/biomedicines10020460. PMID:35203668. IF:4.700(Q1/3D).

01/02/2022 Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer

Pardo, JC, de Porras, VR, Gil, J, Font, A, Puig-Domingo, M, Jorda, M. Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer. Nutrients. 2022; 14(4)DOI:10.3390/nu14040851. PMID:35215499. IF:5.900(Q1/2D).

01/02/2022 Predictors of the need for necrosectomy in patients with walled-off pancreatic necrosis treated with lumen apposition metal stents

Gonzalez-Gonzalez, L, Bazaga, S, Murzi, M, Brujats, A, Trias, M, de Riba, B, Romito, R, Colan-Hernandez, J, Concepcion, M, Gordillo, J, Pernas, JC, Poca, M, Soriano, G, Guarner-Argente, C. Predictors of the need for necrosectomy in patients with walled-off pancreatic necrosis treated with lumen apposition metal stents. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 2022; 36(2)DOI:10.1007/s00464-021-08411-3. PMID:33660124. IF:3.100(Q1/3D).

01/02/2022 Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

Gutierrez, A, Zapater, P, Ricart, E, Gonzalez-Vivo, M, Gordillo, J, Olivares, D, Vera, I, Manosa, M, Gisbert, JP, Aguas, M, Sanchez-Rodriguez, E, Bosca-Watts, M, Laredo, V, Camps, B, Marin-Jimenez, I, Zabana, Y, Martin-Arranz, MD, Munoz, R, Navarro, M, Sierra, E, Madero, L, Vela, M, Perez-Calle, JL, Sainz, E, Calvet, X, Arias, L, Morales, V, Bermejo, F, Fernandez-Salazar, L, Van Domselaar, M, De Castro, L, Rodriguez, C, Munoz-Villafranca, C, Lorente, R, Rivero, M, Iglesias, E, Herreros, B, Busquets, D, Riera, J, Martinez-Montiel, MP, Roldon, M, Roncero, O, Hinojosa, E, Sierra, M, Barrio, J, De Francisco, R, Huguet, J, Merino, O, Carpio, D, Ginard, D, Munoz, F, Marta, P, Almela, P, Argueelles-Arias, F, Alcain, G, Luis, B, Mancenido, N, Lucendo, AJ, Varela, P, Rodriguez-Lago, I, Ramos, L, Laura, S, Sese, E, Acosta, MBD, Domenech, E, Frances, R. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.823900. PMID:35178413. IF:3.900(Q2/4D).

01/02/2022 Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity

Bermudo, G, Suarez-Cuartin, G, Rivera-Ortega, P, Rodriguez-Portal, JA, Sauleda, J, Nunez, B, Castillo, D, Aburto, M, Portillo, K, Balcells, E, Badenes-Bonet, D, Valenzuela, C, Fernandez-Fabrellas, E, Gonzalez-Budino, T, Cano, E, Acosta, O, Leiro-Fernandez, V, Romero, A, Planas-Cerezales, L, Villar, A, Moreno, A, Laporta, R, Vicens-Zygmunt, V, Shull, J, Franquet, T, Luburich, P, Molina-Molina, M. Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(2)DOI:10.1016/j.arbres.2021.03.018. PMID:33895005. IF:8.000(Q1/2D).

01/02/2022 Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies

Plaza, V, Alobid, I, Alvarez, C, Blanco, M, Ferreira, J, Garcia, G, Gomez-Outes, A, Gomez, F, Hidalgo, A, Korta, J, Molina, J, Pellegrini, FJ, Perez, M, Plaza, J, Praena, M, Quirce, S, Sanz, J. Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(2)DOI:10.1016/j.arbres.2021.05.010. PMID:34167859. IF:8.000(Q1/2D).

01/02/2022 The endocrine role of brown adipose tissue: An update on actors and actions

Gavalda-Navarro, A, Villarroya, J, Cereijo, R, Giralt, M, Villarroya, F. The endocrine role of brown adipose tissue: An update on actors and actions. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. 2022; 23(1)DOI:10.1007/s11154-021-09640-6. PMID:33712997. IF:8.200(Q1/1D).

01/02/2022 Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy

Domingo, P, Mateo, MG, Villarroya, J, Cereijo, R, Torres, F, Domingo, JC, Campderros, L, Gallego-Escuredo, JM, Gutierrez, MD, Mur, I, Corbacho, N, Vidal, F, Villarroya, F, Giralt, M. Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy. Journal of Clinical Medicine. 2022; 11(3)DOI:10.3390/jcm11030549. PMID:35160008. IF:3.900(Q2/4D).

01/02/2022 Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy

Yeregui, E, Masip, J, Vilades, C, Domingo, P, Pacheco, YM, Blanco, J, Mallolas, J, Alba, V, Vargas, M, Garcia-Pardo, G, Negredo, E, Olona, M, Vidal-Gonzalez, J, Peraire, M, Marti, A, Reverte, L, Gomez-Bertomeu, F, Leal, M, Vidal, F, Peraire, J, Rull, A. Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042202. PMID:35216318. IF:5.600(Q1/3D).

01/02/2022 A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial

Sooy, RA, Han, JY, Dafni, U, Cho, BC, Yeo, CM, Nadal, E, Carcereny, E, de Castro, J, Sala, MA, Bernabee, R, Coate, L, Pulla, MP, Campelo, RG, Cuffe, S, Hashemi, SMS, Fruh, M, Massuti, B, Garcia-Sanchez, J, Domine, M, Majem, M, Sanchez-Torres, JM, Britschgi, C, Pless, M, Dimopoulou, G, Roschitzki-Voser, H, Ruepp, B, Rosell, R, Stahel, RA, Peters, S. A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial. ANNALS OF ONCOLOGY. 2022; 33(2)DOI:10.1016/j.annonc.2021.11.010. PMID:34839016. IF:50.500(Q1/1D).

01/02/2022 Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study

Pinto Á, Reig O, Iglesias C, Gallardo E, García-Del Muro X, Alonso T, Anguera G, Suárez C, Muñoz-Langa J, Villalobos-León L, Rodríguez-Sánchez Á, Lainez N, Martínez-Ortega E, Campayo M, Velastegui A, Rodriguez-Vida A, Villa-Guzmán JC, Méndez-Vidal MJ, Rubio G, García I, Capdevila L, Lambea J, Vázquez S, Fernández O, Hernando-Polo S, Cerezo S, Santander C, García-Marrero R, Zambrana F, González-Del Alba A, Lazaro-Quintela M, Castellano D, Chirivella I, Anido U, Viana A, García A, Sotelo M, Arévalo MG, García-Donas J, Hernández C, Bolós MV, Llinares J, Climent MA. Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study. Clinical Genitourinary Cancer. 2022; 20(1)DOI:10.1016/j.clgc.2021.09.006. PMID:34789409. IF:3.200(Q2/4D).

01/02/2022 Oral Health-Related Quality of Life Changes in Patients with Dentofacial Deformities Class II and III after Orthognathic Surgery: A Systematic Review and Meta-Analysis

Duarte, V, Zaror, C, Villanueva, J, Andreo, M, Dallaserra, M, Salazar, J, Pont, A, Ferrer, M. Oral Health-Related Quality of Life Changes in Patients with Dentofacial Deformities Class II and III after Orthognathic Surgery: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2022; 19(4)DOI:10.3390/ijerph19041940. PMID:35206128. IF:4.614(Q1/3D).

01/02/2022 Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations

Cortellini, A, Ricciuti, B, Vaz, VR, Soldato, D, Alessi, JV, Dall'Olio, FG, Banna, GL, Muthuramalingam, S, Chan, S, Majem, M, Piedra, A, Lamberti, G, Andrini, E, Addeo, A, Friedlaender, A, Facchinetti, F, Gorria, T, Mezquita, L, Hoton, D, Valerie, L, Nana, FA, Artingstall, J, Comins, C, Di Maio, M, Caglio, A, Cave, J, McKenzie, H, Newsom-Davis, T, Evans, JS, Tiseo, M, D'Alessio, A, Fulgenzi, CAM, Besse, B, Awad, MM, Pinato, DJ. Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations. Journal for ImmunoTherapy of Cancer. 2022; 10(2)DOI:10.1136/jitc-2021-004374. PMID:35173031. IF:10.900(Q1/2D).

01/02/2022 The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients

Dunn, WG, Gu, MXS, Fabre, MA, Cooper, J, Nomdedeu, JF, Koumas, L, Nicolaou, K, Chi, JX, Costeas, P, Vassiliou, GS. The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients. ANNALS OF HEMATOLOGY. 2022; 101(2)DOI:10.1007/s00277-021-04472-5. PMID:33650061. IF:3.500(Q2/5D).

01/02/2022 Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology

Diaz-Riera, E, Garcia-Arguinzonis, M, Lopez, L, Garcia-Moll, X, Badimon, L, Padro, T. Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042344. PMID:35216460. IF:5.600(Q1/3D).

01/02/2022 "The Accessory Ethmoidal Canal Does Not Necessarily Contain an Arterial Structure"

Gras-Cabrerizo, JR, Martel-Martin, M, Villatoro-Sologaistoa, JC, De la Torre, FR, Mirapeix, R, Carrera, A, Montserrat-Gili, JR, Pujol-Olmo, A, Massegur-Solench, H. "The Accessory Ethmoidal Canal Does Not Necessarily Contain an Arterial Structure". ENT-EAR NOSE & THROAT JOURNAL. 2022; 101(2_SUPPL)DOI:10.1177/01455613211049656. PMID:34666559. IF:1.300(Q4/9D).

01/02/2022 Prognostic value of the nodal yield in elective neck dissections in patients with head and neck carcinomas

Leon, X, Venegas, MD, Casasayas, M, Rodriguez, C, Neumann, ED, Holgado, A, Quer, M. Prognostic value of the nodal yield in elective neck dissections in patients with head and neck carcinomas. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2022; 279(2)DOI:10.1007/s00405-021-06819-0. PMID:33938992. IF:2.600(Q2/3D).

01/02/2022 Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation

Martino, R, Garcia-Cadenas, I, Esquirol, A. Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation. BONE MARROW TRANSPLANTATION. 2022; 57(2)DOI:10.1038/s41409-021-01507-3. PMID:34711914. IF:4.800(Q1/2D).

01/02/2022 Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma

Dlouhy, I, Karube, K, Enjuanes, A, Salaverria, I, Nadeu, F, Ramis-Zaldivar, JE, Valero, JG, Rivas-Delgado, A, Magnano, L, Martin-Garcia, D, Perez-Galan, P, Clot, G, Rovira, J, Jares, P, Balague, O, Gine, E, Mozas, P, Briones, J, Sancho, JM, Salar, A, Mercadal, S, Alcoceba, M, Valera, A, Campo, E, Lopez-Guillermo, A. Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY. 2022; 196(3)DOI:10.1111/bjh.17858. PMID:34632572. IF:6.500(Q1/3D).

01/02/2022 Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/ TCF3-PBX1 treated with measurable residual disease-oriented protocols

Ribera, J, Granada, I, Morgades, M, Gonzalez, T, Ciudad, J, Such, E, Calasanz, MJ, Mercadal, S, Coll, R, Gonzalez-Campos, J, Tormo, M, Garcia-Cadenas, I, Gil, C, Cervera, M, Barba, P, Costa, D, Ayala, R, Bermudez, A, Orfao, A, Ribera, JM. Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/ TCF3-PBX1 treated with measurable residual disease-oriented protocols. BRITISH JOURNAL OF HAEMATOLOGY. 2022; 196(3)DOI:10.1111/bjh.17844. PMID:34549416. IF:6.500(Q1/3D).

01/02/2022 Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials

Allan, JN, Shanafelt, T, Wiestner, A, Moreno, C, O'Brien, SM, Li, JL, Krigsfeld, G, Dean, JP, Ahn, IE. Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials. BRITISH JOURNAL OF HAEMATOLOGY. 2022; 196(4)DOI:10.1111/bjh.17984. PMID:34865212. IF:6.500(Q1/3D).

01/02/2022 Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase Ill MabCute study

Rule, S, Barreto, WG, Briones, J, Carella, AM, Casasnovas, O, Pocock, C, Wendtner, CM, Zaja, F, Robson, S, MacGregor, L, Tschopp, RR, Nick, S, Dreyling, M. Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase Ill MabCute study. HAEMATOLOGICA. 2022; 107(2)DOI:10.3324/haematol.2020.274803. PMID:34134469. IF:10.100(Q1/2D).

01/02/2022 Detection of azole resistance in Aspergillus fumigatus complex isolates MALDI-TOF mass

Zvezdanova, ME, Arroyo, MJ, Mendez, G, Candela, A, Mancera, L, Rodriguez, JG, Serra, JL, Jimenez, R, Lozano, I, Castro, C, Lopez, C, Munoz, P, Guinea, J, Escribano, P, Rodriguez-Sanchez, B, Sánchez-Reus F.. Detection of azole resistance in Aspergillus fumigatus complex isolates MALDI-TOF mass. CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(2)DOI:10.1016/j.cmi.2021.06.005. PMID:34147673. IF:14.200(Q1/1D).

01/02/2022 MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transport

Hueso, M, Grinan, R, Mallen, A, Navarro, E, Purqueras, E, Goma, M, Sbraga, F, Blasco-Lucas, A, Revilla, G, Santos, D, Canyelles, M, Julve, J, Escola-Gil, JC, Rotllan, N. MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transport. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022; 146DOI:10.1016/j.biopha.2021.112596. PMID:35062066. IF:7.500(Q1/1D).

31/01/2022 Editorial: Neuroimaging of Cognitive and Neuropsychiatric Symptoms in Movement Disorders

Sampedro, F, Camara, E, Kulisevsky, J. Editorial: Neuroimaging of Cognitive and Neuropsychiatric Symptoms in Movement Disorders. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.843440. PMID:35173676. IF:3.400(Q2/5D).

31/01/2022 Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery

Marcucci, M, Painter, TW, Conen, D, Leslie, K, Lomivorotov, VV, Sessler, D, Chan, MTV, Borges, FK, Zapata, MJM, Wang, CY, Xavier, D, Ofori, SN, Landoni, G, Efremov, S, Kleinlugtenbelt, YV, Szczeklik, W, Schmartz, D, Garg, AX, Short, TG, Wittmann, M, Meyhoff, CS, Amir, M, Torres, D, Patel, A, Duceppe, E, Ruetzler, K, Parlow, JL, Tandon, V, Wang, MK, Fleischmann, E, Polanczyk, CA, Jayaram, R, Astrakov, SV, Rao, M, VanHelder, T, Wu, WKK, Cheong, CC, Ayad, S, Abubakirov, M, Kirov, M, Bhatt, K, de Nadal, M, Likhvantsev, V, Iglesisas, PP, Aguado, HJ, McGillion, M, Lamy, A, Whitlock, RP, Roshanov, P, Stillo, D, Copland, I, Vincent, J, Balasubramanian, K, Bangdiwala, SI, Biccard, B, Kurz, A, Srinathan, S, Petit, S, Eikelboom, J, Richards, T, Gross, PL, Alfonsi, P, Guyatt, G, Belley-Cote, E, Spence, J, McIntyre, W, Yusuf, S, Devereaux, PJ. Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery. Trials. 2022; 23(1)DOI:10.1186/s13063-021-05992-1. PMID:35101083. IF:2.500(Q3/8D).

31/01/2022 NAD plus -Increasing Strategies to Improve Cardiometabolic Health?

Blanco-Vaca, F, Rotllan, N, Canyelles, M, Mauricio, D, Escola-Gil, JC, Julve, J. NAD plus -Increasing Strategies to Improve Cardiometabolic Health?. Frontiers in Endocrinology. 2022; 12DOI:10.3389/fendo.2021.815565. PMID:35173682. IF:5.200(Q1/3D).

29/01/2022 Interim opioid agonist treatment for opioid addiction: a systematic review

Jofra, LS, Puig, T, Sola, I, Trujols, J. Interim opioid agonist treatment for opioid addiction: a systematic review. Harm Reduction Journal. 2022; 19(1)DOI:10.1186/s12954-022-00592-x. PMID:35090475. IF:4.400(Q1/2D).

29/01/2022 Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation position paper

Koller, A, Laughlin, MH, Cenko, E, de Wit, C, Toth, K, Bugiardini, R, Trifunovits, D, Vavlukis, M, Manfrini, O, Lelbach, A, Dornyei, G, Padro, T, Badimon, L, Tousoulis, D, Gielen, S, Duncker, DJ. Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation position paper. CARDIOVASCULAR RESEARCH. 2022; 118(2)DOI:10.1093/cvr/cvab246. PMID:34358290. IF:10.800(Q1/1D).

27/01/2022 Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid

Gobom, J, Parnetti, L, Rosa-Neto, P, Vyhnalek, M, Gauthier, S, Cataldi, S, Lerch, O, Laczo, J, Cechova, K, Clarin, M, Benet, AI, Pascoal, TA, Rahmouni, N, Vandijck, M, Huyck, E, Le Bastard, N, Stevenson, J, Chamoun, M, Alcolea, D, Lleo, A, Andreasson, U, Verbeek, MM, Bellomo, G, Rinaldi, R, Ashton, N, Zetterberg, H, Sheardova, K, Hort, J, Blennow, K. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2022; 60(2)DOI:10.1515/cclm-2021-0651. PMID:34773730. IF:6.800(Q1/2D).